Trials / Completed
CompletedNCT01219608
Iranian Intensive Care Unit (ICU) Glutamine Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Shahid Beheshti University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
This is a double-blinded placebo-controlled block randomized study in intensive care patients comparing enteral glutamine supplementation to placebo. The hypothesis is an improvement of clinical and paraclinical outcomes. The primary endpoint is Infection Probability Score (IPS) and Systemic Inflammatory Response Syndrome (SIRS). Anthropometric measures and serum inflammatory mediators will be compared.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Glutamine 0.5 g/kg/day | Glutamine 0.5 g/kg/day |
| DIETARY_SUPPLEMENT | Glutamine 1 g/kg/day | Glutamine 1 g/kg/day |
| DIETARY_SUPPLEMENT | Enteral Nutrition | Ordinary Enteral Nutrition |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2011-06-01
- Completion
- 2011-06-01
- First posted
- 2010-10-13
- Last updated
- 2011-06-14
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT01219608. Inclusion in this directory is not an endorsement.